Neuropharmacology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.7 | Q1 | 78.4% | 1.568 | Q1 | 92.6% |
| 2024 | 4.6 | Q1 | 84.1% | 1.589 | Q1 | 92.9% |
| 2023 | 4.6 | Q1 | 84.5% | 1.489 | Q1 | 92.6% |
| 2022 | 4.7 | Q1 | 80.4% | 1.307 | Q1 | 91.2% |
| 2021 | 5.3 | Q2 | 80.8% | 1.323 | Q1 | 91.4% |
| 2020 | — | — | 1.760 | Q1 | 94.3% | |
| 2019 | — | — | 1.638 | Q1 | 93.7% | |
| 2018 | — | — | 1.780 | Q1 | 93.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1873-7064
ISSN
0028-3908
country
GBcoverage
1962-2026